Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

January 29, 2029

Study Completion Date

January 29, 2030

Conditions
Myocardial InfarctionCoronary StenosisCoronary Microvascular Dysfunction
Interventions
DRUG

Esmolol Hcl 10Mg/Ml Inj

"the loading dose of 500 mkg/kg for 1 minute, followed by the initial rate of 50 mkg/kg/min. Individual titration depending on the desired hemodynamical effect (to the heart rate of 60 bpm or to the maximum tolerated dose maintaining stable hemodynamics) every 5-15 minutes (the maximum allowed rate of administration is 300 mkg/kg/min) for 6 hours.~Thereafter patients in both treatment arms - the IV esmolol arm and the placebo arm, will be administered oral β-adrenergic blockers, if decided so by the treating physician and unless contraindicated."

Trial Locations (1)

Unknown

RECRUITING

NMRCCardiologyRu, Moscow

All Listed Sponsors
lead

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV